EANDI, Mario
EANDI, Mario
SCIENZA E TECNOLOGIA DEL FARMACO
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: Effects on SK-N-BE and SH-SY5Y Neuroblastoma Cell Lines
2011-01-01 Serpe L; Canaparo R; Zara GP; Eandi M; Frairia R
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: effects on SK-N-BE and SH-SY5Y neuroblastoma cell lines
2011-01-01 L. Serpe; R. Canaparo; F. Foglietta; G.P. Zara; R. Frairia; M. Eandi
A new apomorphine formulation for oral administration
2007-01-01 Zara GP; Cattaldo S; Cavalli R; Calderoni S; Muntoni E; Gasco MR; Mauro A; Eandi M
A Non-Parametric Population PK/PD Analysis Of Tolcapone To Predict L-Dopa Plasma Concentrations
1998-01-01 Costa M; Berno E; Zara GP; Della Pepa C; Canaparo R; Eandi M
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines
2005-01-01 Serpe L; Cavalli R; Guido M; Canaparo R; Muntoni E; Gasco MR; Mauro A; Eandi M; Zara GP
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines
2005-01-01 Serpe L; Cavalli R; Canaparo R; Muntoni E; Gasco MR; Eandi M; Zara GP
Antibiotic dosage individualization through Bayesian inference on PK-PD population data
1996-01-01 Eandi M; Costa M; Della Pepa C; Canaparo R; Zara GP
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data
2003-01-01 CASALE F; COSTA M; CANAPARO R; MUNTONI E; DELLA PEPA C; BERNO E; ZARA GP; PASERO E; EANDI M
Artemisia annua: allestimento di forme farmaceutiche di origine vegetale per i paesi in via di sviluppo - Progetto A.P.P.A.®
2007-01-01 F. Baratta; A. Germano; M. Eandi; P. Brusa
Azione citotossica in vitro del colesterilbutirrato incorporato in nanoparticelle lipidiche solide
2001-01-01 Serpe L; Laurora S; Pizzimenti S; Barrera G; Ugazio E; Gasco MR; Zara GP; Eandi M
Cinetica ematica della gentamicina somministrata per via endovenosa, intramuscolare ed endotracheale nel vitello
1983-01-01 Girardi C.; Farca A.M.; Eandi M.; Viano I.; Celli L.
Cinetica ematiica dell'amminosidina somministrata per via endovenosa, intramuscolare ed endotracheale nel vitello
1983-01-01 Girardi C.; Farca A.M.; Maglione E; Celli L.; Eandi M
Cost-effectiveness of peginterferon α-2a (40 KD) for the treatment of chronic hepatitis B in Italy
2006-01-01 Eandi M; Iannazzo S; Pradelli L; Patel K; Giuliani G.
Cost-effectiveness of preventing recurrent upper respiratory tract infections with a non-specific immunostimulating bacterial extract
2005-01-01 Zaniolo O; Pradelli L; Eandi M.
CYP3A and MDR-1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract
2005-01-01 Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegãrd J; Jeppsson B; Serpe L; Eandi M; Zara GP; Anders R
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract
2005-01-01 Canaparo R; Nordmark A; Finnstrom N; Lundgren S; Seidegard J; Jeppsson B; Serpe L; Muntoni E; Eandi M; Zara GP; Rane A
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract
2005-01-01 Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegård J; Jeppsson B; Serpe L; Eandi M; Zara GP; Rane A
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line
2003-01-01 Serpe L; Catalano MG; Cavalli R; Ugazio E; Muntoni E; Canaparo R; Muntoni E; Frairia R; Gasco MR; Zara GP; Eandi M
Differences between Italian children and adults in thiopurine methyltransferase phenotype and genotype
2005-01-01 Canaparo R; Serpe L; Calvo PL; Barbera C; Muntoni E; Eandi M; Zara GP
Evaluation of antiproliferative activity of cholesteryl butyrate solid lipid nanospheres on leukemic cell lines
2002-01-01 Serpe L; Laurora S; Pizzimenti S; Ugazio E; Ponti R; Barrera G; Gasco MR; Zara GP; Eandi M